Self Injection Market Companies
- BD
- YPSOMED
- West Pharmaceutical Services, Inc.
- Haselmeier
- NuGen Medical Devices
- Owen Mumford Limited
- SHL Medical
- PFIZER INC.
- Amgen Inc.
- Insulet Corporation
- Halozyme, Inc.
- Apikos Pharma & Penardo Biotech Pvt. Ltd.
- Hindustan Syringes & Medical Devices Ltd
- GSK PLC
Recent News:
- According to a recent announcement, the FDA has approved a new single-dose, pre-filled delivery device, named SeflJect injector, to be used for Acthar Gel, a treatment indicated for a various number of chronic and acute inflammatory and autoimmune conditions, including multiple sclerosis (MS) in March 2024.
- Novartis announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection in appropriate patients across all approved US indications in April 2021. 1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.